drug resistance
Untreatable Gonorrhea Rising Globally
Untreatable Gonorrhea Rising Globally
Diana Kwon | Jul 7, 2017
Fifty countries report strains of the bacteria that are resistant to last-resort antibiotics.
Microbe from Yogurt Impedes Drug-Resistant Bacteria
Microbe from Yogurt Impedes Drug-Resistant Bacteria
Aggie Mika | Jun 5, 2017
Lactobacillus parafarraginis metabolites hindered the growth of multiple, distantly related bacterial pathogens. 
Hitting It Out of the Park
Hitting It Out of the Park
Mary Beth Aberlin | Apr 1, 2017
Cancer can be as evasive and slippery as a spitball, but new immunotherapies are starting to connect.
How Cancers Evolve Drug Resistance
How Cancers Evolve Drug Resistance
Anna Azvolinsky | Apr 1, 2017
Researchers unravel the sophisticated ways cancers evade treatments, including immunotherapies, designed to destroy them.
Infographic: Mechanisms of Resistance
Infographic: Mechanisms of Resistance
Anna Azvolinsky | Mar 31, 2017
Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.
WHO Lists Antibiotic Development Priorities
WHO Lists Antibiotic Development Priorities
Tracy Vence | Feb 27, 2017
The World Health Organization outlines critical-, high-, and medium-priority antibiotic development initiatives, calling on the public and private sectors to invest in additional R&D.
Nose Bacterium Inhibits <em>S. aureus</em> Growth
Nose Bacterium Inhibits S. aureus Growth
Kerry Grens | Jul 27, 2016
A study on microbe versus microbe battles within the human nose yields a new antibiotic.
Speaking of Microbiology
Speaking of Microbiology
Tanya Lewis and Tracy Vence | Jun 21, 2016
A selection of notable quotes from the American Society for Microbiology’s annual meeting
Resistance Fighter
Resistance Fighter
Anna Azvolinsky | Jun 1, 2015
Stuart Levy has spent a lifetime studying mechanisms of antibiotic resistance and crusading to abolish the use of antibiotics in animal feed.
Professional Marksman
Professional Marksman
Anna Azvolinsky | Apr 1, 2015
Charles Sawyers, who began his research career just as the genetic details of human oncogenes were emerging, codeveloped Gleevec, the quintessential targeted cancer therapy.